Entrada Therapeutics, Inc.
Institutional holders · 13F as of Mar 31, 2026
| Holder | Value | % of shares |
|---|---|---|
| Renaissance Technologies LLC | $2.55M | 0.52% |
| Morgan Stanley | $2.68M | 0.67% |
| Dimensional Fund Advisors LP | $2.81M | 0.70% |
| Citadel Advisors LLC | $3.01M | 0.75% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.73M | 0.93% |
| STATE STREET CORPORATION | $4.39M | 1.53% |
| Millennium Management LLC | $6.55M | 1.33% |
| StepStone Group LP | $7.83M | 1.96% |
| GEODE CAPITAL MANAGEMENT, LLC | $8.42M | 1.71% |
| Wellington Management Group LLP | $10.74M | 2.68% |
| Merck & Co., Inc. | $12.80M | 4.47% |
| VANGUARD GROUP INC | $16.78M | 4.19% |
| BlackRock, Inc. | $19.01M | 6.63% |
| TCG Crossover Management, LLC | $21.47M | 5.36% |
| 5AM Venture Management, LLC | $41.70M | 10.42% |
| Baker Bros. Advisors LP | $64.02M | 13.03% |